FDA inspection

Biospring Gmbh: FDA inspection ending Jan 16, 2018

FDA inspection 1042485 · No Action Indicated (NAI) · Frankfurt am Main

Key facts

Inspection ID 1042485
Firm Biospring Gmbh
FEI number 3005115446
Address Alt-Fechenheim 34
City Frankfurt am Main
Country Germany
Fiscal year 2018
Inspection end date Jan 16, 2018
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections